Fresenius Medical Care posts Q2 operating income rise of 20%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
August 3, 2026 2:20 PM EDTOrganic revenue growth1Â of 5% with growth in all operating segmentsOperating income2Â grew by 23%, resulting in further margin expansion to 11.7%Reported operating income grew by 10% and reported net income3Â decreased by 3%Earnings per share2 (EPS) increased by 28%, supported by the share buyback program227 U.S. clinics converted to the 5008X CAREsystem with more than 600,000 treatments4Reaffirms FY 2026 outlook
BAD HOMBURG, Germany,... More



